IGC PHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $14.4M | $1.1M |
| FY2014 | $0 | $13.6M | $1.0M |
| FY2015 | $323.9K | $14.2M | $824.5K |
| FY2016 | $801.5K | $13.5M | $1.5M |
| FY2017 | $452.1K | $7.4M | $538.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $14.4M | $1.1M |
| FY2014 | $0 | $13.6M | $1.0M |
| FY2015 | $323.9K | $14.2M | $824.5K |
| FY2016 | $801.5K | $13.5M | $1.5M |
| FY2017 | $452.1K | $7.4M | $538.0K |